Boston Scientific Shares Outstanding 2006-2018 | BSX

Boston Scientific shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Boston Scientific shares outstanding for the quarter ending September 30, 2018 were 1.404B, a 0.7% increase year-over-year.
  • Boston Scientific 2017 shares outstanding were 1.393B, a 1.13% increase from 2016.
  • Boston Scientific 2016 shares outstanding were 1.377B, a 2.68% increase from 2015.
  • Boston Scientific 2015 shares outstanding were 1.341B, a 1.28% increase from 2014.
Boston Scientific Annual Shares Outstanding
(Millions of Shares)
2017 1,393
2016 1,377
2015 1,341
2014 1,324
2013 1,341
2012 1,407
2011 1,519
2010 1,518
2009 1,508
2008 1,499
2007 1,487
2006 1,274
2005 838
Boston Scientific Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 1,404
Q2 2018 1,399
Q1 2018 1,397
Q4 2017 1,393
Q3 2017 1,394
Q2 2017 1,391
Q1 2017 1,390
Q4 2016 1,377
Q3 2016 1,380
Q2 2016 1,357
Q1 2016 1,370
Q4 2015 1,341
Q3 2015 1,344
Q2 2015 1,362
Q1 2015 1,334
Q4 2014 1,324
Q3 2014 1,348
Q2 2014 1,345
Q1 2014 1,349
Q4 2013 1,341
Q3 2013 1,340
Q2 2013 1,359
Q1 2013 1,352
Q4 2012 1,407
Q3 2012 1,393
Q2 2012 1,423
Q1 2012 1,454
Q4 2011 1,519
Q3 2011 1,524
Q2 2011 1,536
Q1 2011 1,536
Q4 2010 1,518
Q3 2010 1,529
Q2 2010 1,525
Q1 2010 1,515
Q4 2009 1,508
Q3 2009 1,509
Q2 2009 1,515
Q1 2009 1,505
Q4 2008 1,499
Q3 2008 1,501
Q2 2008 1,505
Q1 2008 1,500
Q4 2007 1,487
Q3 2007 1,490
Q2 2007 1,500
Q1 2007 1,498
Q4 2006 1,274
Q3 2006 1,487
Q2 2006 1,327
Q1 2006 830
Q4 2005 838
Q3 2005 820
Q2 2005 840
Q1 2005 850
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.097B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.569B 18.92
Abbott Laboratories (ABT) United States $122.855B 24.89
Stryker (SYK) United States $63.182B 23.82
Baxter (BAX) United States $34.600B 22.34
Zimmer Biomet Holdings (ZBH) United States $22.421B 14.54
Smith & Nephew SNATS (SNN) United Kingdom $16.589B 0.00
ResMed (RMD) United States $15.674B 29.89
Perrigo (PRGO) Ireland $8.142B 12.36
Bio-Rad Laboratories (BIO) United States $7.677B 49.09
Canopy Growth (CGC) Canada $7.290B 0.00
Hill-Rom Holdings (HRC) United States $6.241B 19.53
Aurora Cannabis (ACB) Canada $5.730B 30.26
Haemonetics (HAE) United States $5.332B 46.90
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.752B 26.48
Hutchison China MediTech (HCM) China $4.204B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.765B 0.00
Neogen (NEOG) United States $3.198B 48.43
Agios Pharmaceuticals (AGIO) United States $3.093B 0.00
NuVasive (NUVA) United States $2.886B 26.85
National Vision Holdings (EYE) United States $2.497B 48.30
NxStage Medical (NXTM) United States $1.925B 0.00
Quidel (QDEL) United States $1.917B 24.99
Phibro Animal Health (PAHC) United States $1.327B 18.78
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.204B 0.00
Cardiovascular Systems (CSII) United States $0.991B 1428.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.886B 22.96
Meridian Bioscience (VIVO) United States $0.778B 24.80
Surmodics (SRDX) United States $0.766B 116.65
OraSure Technologies (OSUR) United States $0.752B 42.35
Cerus (CERS) United States $0.726B 0.00
MacroGenics (MGNX) United States $0.693B 0.00
Omeros (OMER) United States $0.687B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.00
Lantheus Holdings (LNTH) United States $0.652B 20.17
NanoString Technologies (NSTG) United States $0.527B 0.00
LeMaitre Vascular (LMAT) United States $0.502B 24.65
Owens & Minor (OMI) United States $0.433B 4.90
Quanterix (QTRX) United States $0.433B 0.00
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.385B 0.00
Evolus (EOLS) United States $0.375B 0.00
VAPOTHERM INC (VAPO) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.90
Cytosorbents (CTSO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.207B 279.25
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.135B 6.77
Imprimis Pharmaceuticals (IMMY) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.079B 16.53
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.27
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.052B 0.00
Neurotrope (NTRP) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00